Download PDF
Semin Respir Crit Care Med 2018; 39(04): 482-493
DOI: 10.1055/s-0038-1668533
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Alveolar Hemorrhage in Vasculitis (Primary and Secondary)

Mouhamad Nasser
1   Department of Respiratory Medicine, Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Lyon, France
,
Vincent Cottin
1   Department of Respiratory Medicine, Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Lyon, France
2   Claude Bernard Lyon 1 University, University of Lyon, INRA, Lyon, France
› Author Affiliations
Further Information

Publication History

Publication Date:
07 November 2018 (online)

    Permissions and Reprints

Abstract

Defined by the accumulation of red blood cells into the alveolar space, diffuse alveolar hemorrhage (DAH) is a severe and potentially fatal medical condition requiring careful attention. In contrast to simple extravasation of erythrocytes facilitated by impaired hemostasis or hemodynamic causes, DAH in vasculitis is due to capillaritis, that is, inflammation of capillaries. Dyspnea, hemoptysis, chest infiltrates, and abrupt fall of blood hemoglobin level represent the cardinal features of DAH; yet, hemoptysis is lacking in one-third of cases. Bronchoalveolar lavage, retrieving bright red fluid, is the best diagnostic clue, also excluding infection and other causes of hemoptysis. Although not recommended, lung biopsy is the gold standard for the diagnosis of DAH and pulmonary capillaritis. Pulmonary capillaritis may be primary as in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis or secondary to drugs (especially antithyroid drugs such as propylthiouracil), infections, connective tissue diseases especially systemic lupus erythematosus, or other small vessel vasculitides. Newer toxic causes of drugs of abuse may be difficult to diagnose. Granulomatosis with polyangiitis and microscopic polyangiitis are the most common causes of capillaritis and DAH, whereas DAH is extremely rare in eosinophilic granulomatosis with polyangiitis. When pulmonary capillaritis is not secondary to underlying systemic vasculitis, idiopathic pauci-immune pulmonary capillaritis may be considered, with or without ANCA. Supportive treatment strategy is mandatory in all cases of DAH. Mechanical ventilation and extracorporeal membrane oxygenation may be used in severe cases. Early identification and removal of the putative drug is crucial in drug-induced vasculitis/DAH and may obviate the need for immunosuppressive therapy. High-dose corticosteroids, intravenous cyclophosphamide, and recently rituximab are the mainstay of treatment in vasculitis. Plasma exchange is recommended in anti–glomerular basement membrane disease and in severe DAH associated with systemic lupus erythematosus and is used in selected cases in ANCA-associated vasculitis.

Keywords

diffuse alveolar hemorrhage - pulmonary vasculitis - connective tissue disease - ANCA-associated vasculitis - respiratory failure - rituximab
 

  • References

  • 1 Thompson G, Klecka M, Roden AC, Specks U, Cartin-Ceba R. Biopsy-proven pulmonary capillaritis: a retrospective study of aetiologies including an in-depth look at isolated pulmonary capillaritis. Respirology 2016; 21 (04) 734-738
    CrossrefPubMedGoogle Scholar
  • 2 de Prost N, Parrot A, Picard C. , et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J 2010; 35 (06) 1303-1311
    CrossrefPubMedGoogle Scholar
  • 3 Quadrelli S, Dubinsky D, Solis M. , et al. Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med 2017; 129: 59-62
    CrossrefPubMedGoogle Scholar
  • 4 Primack SL, Miller RR, Müller NL. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. AJR Am J Roentgenol 1995; 164 (02) 295-300
    CrossrefPubMedGoogle Scholar
  • 5 Lauque D, Cadranel J, Lazor R. , et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). Medicine (Baltimore) 2000; 79 (04) 222-233
    PubMedGoogle Scholar
  • 6 Chung MP, Yi CA, Lee HY, Han J, Lee KS. Imaging of pulmonary vasculitis. Radiology 2010; 255 (02) 322-341
    CrossrefPubMedGoogle Scholar
  • 7 Fernandez Casares M, Gonzalez A, Fielli M, Caputo F, Bottinelli Y, Zamboni M. Microscopic polyangiitis associated with pulmonary fibrosis. Clin Rheumatol 2015; 34 (07) 1273-1277
    CrossrefPubMedGoogle Scholar
  • 8 Tanaka T, Otani K, Egashira R. , et al. Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients. Respir Med 2012; 106 (12) 1765-1770
    CrossrefPubMedGoogle Scholar
  • 9 Hosoda C, Baba T, Hagiwara E. , et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Respirology 2016; 21 (05) 920-926
    CrossrefPubMedGoogle Scholar
  • 10 De Lassence A, Fleury-Feith J, Escudier E, Beaune J, Bernaudin J-F, Cordonnier C. Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 1995; 151 (01) 157-163
    CrossrefPubMedGoogle Scholar
  • 11 Golde DW, Drew WL, Klein HZ, Finley TN, Cline MJ. Occult pulmonary haemorrhage in leukaemia. BMJ 1975; 2 (5964): 166-168
    CrossrefPubMedGoogle Scholar
  • 12 Kahn FW, Jones JM, England DM. Diagnosis of pulmonary hemorrhage in the immunocompromised host. Am Rev Respir Dis 1987; 136 (01) 155-160
    CrossrefPubMedGoogle Scholar
  • 13 Maldonado F, Parambil JG, Yi ES, Decker PA, Ryu JH. Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage. Eur Respir J 2009; 33 (06) 1361-1366
    CrossrefPubMedGoogle Scholar
  • 14 Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med 2008; 75 (04) 258 , 260, 264–265 passim
    CrossrefPubMedGoogle Scholar
  • 15 Rolla G, Heffler E, Guida G, Bergia R, Bucca C. Exhaled NO in diffuse alveolar haemorrhage. Thorax 2005; 60 (07) 614-615
    CrossrefPubMedGoogle Scholar
  • 16 Cordier JF. A lung biopsy is unnecessary in the management of ANCA-positive patients with chest-roentgenographic abnormalities. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13 (03) 235-237
    PubMedGoogle Scholar
  • 17 Myers JL, Katzenstein AL. Wegener's granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. Am J Surg Pathol 1987; 11 (11) 895-898
    CrossrefPubMedGoogle Scholar
  • 18 Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990; 14 (12) 1112-1125
    CrossrefPubMedGoogle Scholar
  • 19 Cordier J-F, Cottin V. Alveolar hemorrhage in vasculitis: primary and secondary. Semin Respir Crit Care Med 2011; 32 (03) 310-321
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Imoto EM, Lombard CM, Sachs DP. Pulmonary capillaritis and hemorrhage. A clue to the diagnosis of systemic necrotizing vasculitis. Chest 1989; 96 (04) 927-928
    CrossrefPubMedGoogle Scholar
  • 21 Jennette JC, Falk RJ, Bacon PA. , et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 22 Carruthers DM, Watts RA, Symmons DP, Scott DG. Wegener's granulomatosis--increased incidence or increased recognition?. Br J Rheumatol 1996; 35 (02) 142-145
    CrossrefPubMedGoogle Scholar
  • 23 Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004; 51 (01) 92-99
    CrossrefPubMedGoogle Scholar
  • 24 Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 2007; 46 (08) 1329-1337
    CrossrefPubMedGoogle Scholar
  • 25 O'Donnell JL, Stevanovic VR, Frampton C, Stamp LK, Chapman PT. Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Intern Med J 2007; 37 (04) 242-246
    CrossrefPubMedGoogle Scholar
  • 26 Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides?. Best Pract Res Clin Rheumatol 2005; 19 (02) 191-207
    CrossrefPubMedGoogle Scholar
  • 27 Casian A, Berden A, Jayne D. Alveolar haemorrhage in ANCA associated vasculitis: a retrospective analysis from the European Vasculitis Study Group. NDT Plus 2010; 3 (Suppl. 03) 278
    PubMedGoogle Scholar
  • 28 Lin Y, Zheng W, Tian X, Zhang X, Zhang F, Dong Y. Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: a study of 12 cases. J Clin Rheumatol 2009; 15 (07) 341-344
    CrossrefPubMedGoogle Scholar
  • 29 Oh JS, Lee C-K, Kim YG, Nah S-S, Moon H-B, Yoo B. Clinical features and outcomes of microscopic polyangiitis in Korea. J Korean Med Sci 2009; 24 (02) 269-274
    CrossrefPubMedGoogle Scholar
  • 30 Kostianovsky A, Hauser T, Pagnoux C. , et al; French Vasculitis Study Group (FVSG). Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors. Clin Exp Rheumatol 2012; 30 (01) (Suppl. 70) S77-S82
    PubMedGoogle Scholar
  • 31 Wilke L, Prince-Fiocco M, Fiocco GP. Microscopic polyangiitis: a large single-center series. J Clin Rheumatol 2014; 20 (04) 179-182
    CrossrefPubMedGoogle Scholar
  • 32 Villiger PM, Guillevin L. Microscopic polyangiitis: clinical presentation. Autoimmun Rev 2010; 9 (12) 812-819
    CrossrefPubMedGoogle Scholar
  • 33 Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7 (01) 23-32
    PubMedGoogle Scholar
  • 34 Guillevin L, Durand-Gasselin B, Cevallos R. , et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42 (03) 421-430
    CrossrefPubMedGoogle Scholar
  • 35 Schwarz MI, Brown KK. Small vessel vasculitis of the lung. Thorax 2000; 55 (06) 502-510
    CrossrefPubMedGoogle Scholar
  • 36 Comarmond C, Crestani B, Tazi A. , et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore) 2014; 93 (24) 340-349
    PubMedGoogle Scholar
  • 37 Kagiyama N, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis. BMJ Open Respir Res 2015; 2 (01) e000058
    PubMedGoogle Scholar
  • 38 Birnbaum J, Danoff S, Askin FB, Stone JH. Microscopic polyangiitis presenting as a “pulmonary-muscle” syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?. Arthritis Rheum 2007; 56 (06) 2065-2071
    CrossrefPubMedGoogle Scholar
  • 39 Hoffman GS, Kerr GS, Leavitt RY. , et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116 (06) 488-498
    CrossrefPubMedGoogle Scholar
  • 40 Cordier J-F, Valeyre D, Guillevin L, Loire R, Brechot J-M. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest 1990; 97 (04) 906-912
    CrossrefPubMedGoogle Scholar
  • 41 Sauvaget F, Lê Thi Huong Du, Piette JC. , et al. Intra-alveolar hemorrhage in Wegener's granulomatosis. Retrospective study of 9 cases [in French]. Presse Med 1993; 22 (15) 709-711
    PubMedGoogle Scholar
  • 42 Han TS, Mahon RT. Wegener's granulomatosis presenting with diffuse alveolar hemorrhage and negative antineutrophilic cytoplasmic antibody test. Mil Med 2006; 171 (08) 781-783
    CrossrefPubMedGoogle Scholar
  • 43 Habu Y, Akamatsu K, Kuroda M. , et al. [Two cases of anti-neutrophil cytoplasmic antibody-negative generalized Wegener's granulomatosis with alveolar hemorrhage]. Nihon Kokyuki Gakkai Zasshi 1998; 36 (02) 157-163
    PubMedGoogle Scholar
  • 44 Bosch X. Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis. Ann Rheum Dis 1999; 58 (10) 644-647
    CrossrefPubMedGoogle Scholar
  • 45 Sinico RA, Di Toma L, Maggiore U. , et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005; 52 (09) 2926-2935
    CrossrefPubMedGoogle Scholar
  • 46 Sablé-Fourtassou R, Cohen P, Mahr A. , et al; French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143 (09) 632-638
    PubMedGoogle Scholar
  • 47 Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78 (01) 26-37
    PubMedGoogle Scholar
  • 48 Keogh KA, Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003; 115 (04) 284-290
    CrossrefPubMedGoogle Scholar
  • 49 Solans R, Bosch JA, Pérez-Bocanegra C. , et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford) 2001; 40 (07) 763-771
    CrossrefPubMedGoogle Scholar
  • 50 Della Rossa A, Baldini C, Tavoni A. , et al. Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. Rheumatology (Oxford) 2002; 41 (11) 1286-1294
    CrossrefPubMedGoogle Scholar
  • 51 Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003; 42 (06) 1149-1153
    CrossrefPubMedGoogle Scholar
  • 52 Cottin V, Bel E, Bottero P. , et al. Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P). Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev 2017; 16 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 53 Jennings CA, King Jr TE, Tuder R, Cherniack RM, Schwarz MI. Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med 1997; 155 (03) 1101-1109
    CrossrefPubMedGoogle Scholar
  • 54 Gupta A, Joneja M, D'Arsigny C, Liak C. Isolated pauci-immune pulmonary capillaritis presenting as diffuse alveolar hemorrhage. Am J Respir Crit Care Med 2017; 195: A1463
    PubMedGoogle Scholar
  • 55 Monteiro AS, Addor G, Nigri DH, Torres W, Franco CAdB. Diffuse alveolar hemorrhage resulting from pauci-immune pulmonary capillaritis. J Pneumol 2003; 29: 217-220
    CrossrefPubMedGoogle Scholar
  • 56 Seo P. Cases from the medical grand rounds of the Osler Medical Service at Johns Hopkins University. Am J Med 2002; 112 (09) 730-732
    CrossrefPubMedGoogle Scholar
  • 57 Thompson G, Specks U, Cartin-Ceba R. Isolated pauciimmune pulmonary capillaritis successfully treated with rituximab. Chest 2015; 147 (04) e134-e136
    CrossrefPubMedGoogle Scholar
  • 58 Koh WH, Thumboo J, Boey ML. Pulmonary haemorrhage in Oriental patients with systemic lupus erythematosus. Lupus 1997; 6 (09) 713-716
    CrossrefPubMedGoogle Scholar
  • 59 Badsha H, Teh CL, Kong KO, Lian TY, Chng HH. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004; 33 (06) 414-421
    CrossrefPubMedGoogle Scholar
  • 60 Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997; 76 (03) 192-202
    PubMedGoogle Scholar
  • 61 Andrade C, Mendonça T, Farinha F. , et al. Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus 2016; 25 (01) 75-80
    CrossrefPubMedGoogle Scholar
  • 62 Kazzaz NM, Coit P, Lewis EE, McCune WJ, Sawalha AH, Knight JS. Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival. Lupus Sci Med 2015; 2 (01) e000117
    CrossrefPubMedGoogle Scholar
  • 63 Kwok SK, Moon SJ, Ju JH. , et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Lupus 2011; 20 (01) 102-107
    CrossrefPubMedGoogle Scholar
  • 64 Martínez-Martínez MU, Abud-Mendoza C. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus 2011; 20 (06) 568-574
    CrossrefPubMedGoogle Scholar
  • 65 Ednalino C, Yip J, Carsons SE. Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: focus on outcome and therapy. J Clin Rheumatol 2015; 21 (06) 305-310
    CrossrefPubMedGoogle Scholar
  • 66 Verzegnassi F, Marchetti F, Zennaro F, Saccari A, Ventura A, Lepore L. Prompt efficacy of plasmapheresis in a patient with systemic lupus erythematosus and diffuse alveolar haemorrhage. Clin Exp Rheumatol 2010; 28 (03) 445-446
    PubMedGoogle Scholar
  • 67 Sakamoto A, Ashitani J, Imai K. , et al. [A case of diffuse alveolar hemorrhage occurring during the course of rheumatoid arthritis]. Nihon Kokyuki Gakkai Zasshi 2010; 48 (09) 672-676
    PubMedGoogle Scholar
  • 68 Dua R, Rawat J. Diffuse alveolar hemorrhage in a patient of rheumatoid arthritis. Lung India 2014; 31 (02) 194-195
    CrossrefPubMedGoogle Scholar
  • 69 Schwarz MI, Zamora MR, Hodges TN, Chan ED, Bowler RP, Tuder RM. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998; 113 (06) 1609-1615
    CrossrefPubMedGoogle Scholar
  • 70 Khaja M, Menon L, Niazi M, Fuentes GD. Diffuse alveolar hemorrhage and acute respiratory distress syndrome during treatment of rheumatoid arthritis with etanercept. J Bronchology Interv Pulmonol 2012; 19 (03) 228-231
    CrossrefPubMedGoogle Scholar
  • 71 Horiki T, Fuyuno G, Ishii M. , et al. Fatal alveolar hemorrhage in a patient with mixed connective tissue disease presenting polymyositis features. Intern Med 1998; 37 (06) 554-560
    CrossrefPubMedGoogle Scholar
  • 72 Tomita Y, Mori S, Arima N, Fukuda K, Kohrogi H. Rapidly progressive pulmonary fibrosis following the onset of diffuse alveolar hemorrhage in Sjögren's syndrome: an autopsy case report. Intern Med 2012; 51 (03) 295-299
    CrossrefPubMedGoogle Scholar
  • 73 Naniwa T, Banno S, Sugiura Y. , et al. Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature. Mod Rheumatol 2007; 17 (01) 37-44
    CrossrefPubMedGoogle Scholar
  • 74 Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, Gur H. Pulmonary-renal syndrome in systemic sclerosis. Semin Arthritis Rheum 2001; 30 (06) 403-410
    CrossrefPubMedGoogle Scholar
  • 75 Casari S, Haeney M, Farrand S, Herrick A. Antineutrophil cytoplasmic antibodies a “Red Flag” in patients with systemic sclerosis. J Rheumatol 2002; 29 (12) 2666-2667
    PubMedGoogle Scholar
  • 76 Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994; 21 (05) 864-870
    PubMedGoogle Scholar
  • 77 Defendenti C, Spina MF, Castiglione A. , et al. Alveolar hemorrhage in pulmonary-renal syndrome anti-SCL/70 and anti-MPO-ANCA positive [in Italian]. Recenti Prog Med 2009; 100 (7-8): 361-364
    PubMedGoogle Scholar
  • 78 Shoda T, Kotani T, Takeuchi T, Makino S, Hanafusa T. A fulminant case of systemic sclerosis/dermatomyositis complicating thrombotic microangiopathy and diffuse alveolar hemorrhage [in Japanese]. Nihon Kokyuki Gakkai Zasshi 2009; 47 (03) 227-231
    PubMedGoogle Scholar
  • 79 Do-Pham G, Pagès C, Picard C. , et al. A first case report of a patient with paraneoplastic dermatomyositis developing diffuse alveolar haemorrhage. Br J Dermatol 2010; 163 (01) 227-228
    PubMedGoogle Scholar
  • 80 Sato K, Morozumi S, Takeuchi Y, Ochiai J, Mabuchi C. Case of dermatomyositis with anti-CADM-140 antibody and alveolar hemorrhage [in Japanese]. Rinsho Shinkeigaku 2014; 54 (05) 408-412
    CrossrefPubMedGoogle Scholar
  • 81 Schwarz MI, Sutarik JM, Nick JA, Leff JA, Emlen JW, Tuder RM. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med 1995; 151 (06) 2037-2040
    CrossrefPubMedGoogle Scholar
  • 82 DE Zoysa J, Taylor D, Thein H, Yehia M. Incidence and features of dual anti-GBM-positive and ANCA-positive patients. Nephrology (Carlton) 2011; 16 (08) 725-729
    CrossrefPubMedGoogle Scholar
  • 83 Fischer EG, Lager DJ. Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol 2006; 125 (03) 445-450
    CrossrefPubMedGoogle Scholar
  • 84 Li FK, Tse KC, Lam MF. , et al. Incidence and outcome of antiglomerular basement membrane disease in Chinese. Nephrology (Carlton) 2004; 9 (02) 100-104
    CrossrefPubMedGoogle Scholar
  • 85 Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967; 126 (06) 989-1004
    CrossrefPubMedGoogle Scholar
  • 86 Borza D-B, Hudson BG. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease. Springer Semin Immunopathol 2003; 24 (04) 345-361
    CrossrefPubMedGoogle Scholar
  • 87 Pedchenko V, Vanacore R, Hudson B. Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis. Curr Opin Nephrol Hypertens 2011; 20 (03) 290-296
    CrossrefPubMedGoogle Scholar
  • 88 Lazor R, Bigay-Gamé L, Cottin V. , et al; Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMOP); Swiss Group for Interstitial and Orphan Lung Diseases (SIOLD). Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine (Baltimore) 2007; 86 (03) 181-193
    PubMedGoogle Scholar
  • 89 Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990; 37 (03) 965-970
    CrossrefPubMedGoogle Scholar
  • 90 Yang G, Tang Z, Chen Y. , et al. Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis. Clin Nephrol 2005; 63 (06) 423-428
    CrossrefPubMedGoogle Scholar
  • 91 Nakabayashi K, Fujioka Y, Nagasawa T. , et al. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Clin Exp Nephrol 2011; 15 (04) 614
    CrossrefPubMedGoogle Scholar
  • 92 Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997; 8 (03) 376-385
    PubMedGoogle Scholar
  • 93 Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract 2003; 94 (03) c59-c68
    PubMedGoogle Scholar
  • 94 McAdoo SP, Tanna A, Hrušková Z. , et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 2017; 92 (03) 693-702
    CrossrefPubMedGoogle Scholar
  • 95 Johnson JP, Moore Jr J, Austin III HA, Balow JE, Antonovych TT, Wilson CB. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985; 64 (04) 219-227
    PubMedGoogle Scholar
  • 96 Ito Y, Arita M, Kumagai S. , et al. Diffuse alveolar hemorrhage in IgA vasculitis with an atypical presentation. Intern Med 2018; 57 (01) 81-84
    CrossrefPubMedGoogle Scholar
  • 97 Shichiri M, Tsutsumi K, Yamamoto I, Ida T, Iwamoto H. Diffuse intrapulmonary hemorrhage and renal failure in adult Henoch-Schönlein purpura. Am J Nephrol 1987; 7 (02) 140-142
    CrossrefPubMedGoogle Scholar
  • 98 Pourcelet A, Georgery M, Vandergheynst F, Hougardy J-M, De Breucker S. An exceptional cause of hemoptysis in the elderly patient : IgA vasculitis. Acta Clin Belg 2017; 73: 1-2
    PubMedGoogle Scholar
  • 99 Rajagopala S, Parameswaran S, Ajmera JS, Ganesh RN, Katrevula A. Diffuse alveolar hemorrhage in IgA nephropathy: case series and systematic review of the literature. Int J Rheum Dis 2017; 20 (01) 109-121
    CrossrefPubMedGoogle Scholar
  • 100 Chen M, Gao Y, Guo X-H, Zhao M-H. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol 2012; 8 (08) 476-483
    PubMedGoogle Scholar
  • 101 Gao Y, Zhao MH. Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 2009; 14 (01) 33-41
    CrossrefPubMedGoogle Scholar
  • 102 Yazisiz V, Ongüt G, Terzioğlu E, Karayalçin U. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. Int J Clin Pract 2010; 64 (01) 19-24
    CrossrefPubMedGoogle Scholar
  • 103 Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000; 43 (02) 405-413
    CrossrefPubMedGoogle Scholar
  • 104 Calañas-Continente A, Espinosa M, Manzano-García G, Santamaría R, Lopez-Rubio F, Aljama P. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy. Thyroid 2005; 15 (03) 286-288
    CrossrefPubMedGoogle Scholar
  • 105 Thong H-Y, Chu C-Y, Chiu H-C. Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Acta Derm Venereol 2002; 82 (03) 206-208
    PubMedGoogle Scholar
  • 106 Nicolls MR, Terada LS, Tuder RM, Prindiville SA, Schwarz MI. Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med 1998; 158 (04) 1302-1305
    CrossrefPubMedGoogle Scholar
  • 107 Schwarz MI, Fontenot AP. Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 2004; 25 (01) 133-140
    CrossrefPubMedGoogle Scholar
  • 108 Grau RG. Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep 2015; 17 (12) 71
    CrossrefPubMedGoogle Scholar
  • 109 Picard C, Cadranel J, Porcher R. , et al. Alveolar haemorrhage in the immunocompetent host: a scale for early diagnosis of an immune cause. Respiration 2010; 80 (04) 313-320
    CrossrefPubMedGoogle Scholar
  • 110 de Prost N, Parrot A, Cuquemelle E, Picard C, Cadranel J. Immune diffuse alveolar hemorrhage: a retrospective assessment of a diagnostic scale. Lung 2013; 191 (05) 559-563
    CrossrefPubMedGoogle Scholar
  • 111 Casian A, Jayne D. Management of alveolar hemorrhage in lung vasculitides. Semin Respir Crit Care Med 2011; 32 (03) 335-345
    Article in Thieme ConnectPubMedGoogle Scholar
  • 112 Ravindran V, Watts RA. Pulmonary haemorrhage in ANCA-associated vasculitis. Rheumatology (Oxford) 2010; 49 (07) 1410-1412
    CrossrefPubMedGoogle Scholar
  • 113 Jones RB, Tervaert JW, Hauser T. , et al; European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363 (03) 211-220
    CrossrefPubMedGoogle Scholar
  • 114 Stone JH, Merkel PA, Spiera R. , et al; RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363 (03) 221-232
    CrossrefPubMedGoogle Scholar
  • 115 Guillevin L, Pagnoux C, Karras A. , et al; French Vasculitis Study Group. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 2014; 371 (19) 1771-1780
    CrossrefPubMedGoogle Scholar
  • 116 Charles P, Terrier B, Perrodeau É. , et al; French Vasculitis Study Group. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). Ann Rheum Dis 2018; 77 (08) 1143-1149
    CrossrefPubMedGoogle Scholar
  • 117 Aakjær S, Bendstrup E, Ivarsen P, Madsen LB. Continuous rituximab treatment for recurrent diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Respir Med Case Rep 2017; 22: 263-265
    PubMedGoogle Scholar
  • 118 Montes-Rivera G, Ríos G, Vilá LM. Efficacy of rituximab in a systemic lupus erythematosus patient presenting with diffuse alveolar hemorrhage. Case Rep Rheumatol 2017; 2017: 6031053
    PubMedGoogle Scholar
  • 119 Tse JR, Schwab KE, McMahon M, Simon W. Rituximab: an emerging treatment for recurrent diffuse alveolar hemorrhage in systemic lupus erythematosus. Lupus 2015; 24 (07) 756-759
    CrossrefPubMedGoogle Scholar
  • 120 Baeza-Trinidad R, Rosel-Rioja L. Wegener's intra-alveolar hemorrhage remission with rituximab. QJM 2014; 107 (09) 773-774
    CrossrefPubMedGoogle Scholar
  • 121 Pathak V, Kuhn J, Gabriel D, Barrow J, Jennette JC, Henke DC. Use of activated factor VII in patients with diffuse alveolar hemorrhage: a 10 years institutional experience. Lung 2015; 193 (03) 375-379
    CrossrefPubMedGoogle Scholar
  • 122 Baker MS, Diab KJ, Carlos WG, Mathur P. Intrapulmonary recombinant factor VII as an effective treatment for diffuse alveolar hemorrhage: a case series. J Bronchology Interv Pulmonol 2016; 23 (03) 255-258
    CrossrefPubMedGoogle Scholar
  • 123 Abrams D, Agerstrand CL, Biscotti M, Burkart KM, Bacchetta M, Brodie D. Extracorporeal membrane oxygenation in the management of diffuse alveolar hemorrhage. ASAIO J 2015; 61 (02) 216-218
    CrossrefPubMedGoogle Scholar
  • 124 Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO. , et al. Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes. Arthritis Rheumatol 2016; 68 (06) 1467-1476
    PubMedGoogle Scholar